Leading of lenvatyra 4 lenvatinib 4mg lenvima capsule, lenvatyra 10 lenvatinib 10mg lenvima capsule, bdenza 80mg enzalutamide 80mg capsule xtandi, bdenza 40mg enzalutamide 40mg capsule xtandi, bdenza 160mg enzalutamide 160mg capsule xtandi and erlocip 150 erlotinib tablet tarceva from Nagpur.
₹ 2700 / Box Get Latest Price
| Strength | 4 mg |
| Brand | Lenvatyra |
| Capsules per Pack | 10 Capsules |
| Usage | Liver Cancer, Cancer Care, Thyroid Cancer, Renal Cancer |
| Form | Capsule |
| Pack Type | Bottle |
| Manufacturer | Medyra Pharmacueticals |
Lenvatyra 4 Capsules
Composition: Lenvatinib Capsules 4mg
International Trade Name: Lenvima®
Lenvatyra 4 is a high-quality Lenvatinib 4mg capsule supplied by a trusted pharmaceutical exporter from India. This formulation contains Lenvatinib 4mg, internationally recognized under the brand name Lenvima, and is widely used in targeted therapy for oncology treatment protocols.
Lenvatyra 4 Capsules are primarily indicated for the management of hepatocellular carcinoma, thyroid cancer, and endometrial cancer, either as monotherapy or in combination with other anticancer agents. Lenvatinib is a multikinase inhibitor that targets VEGFR, FGFR, PDGFR, RET, and KIT, inhibiting tumor angiogenesis and cancer cell proliferation.
High-ranking search keywords include Lenvatinib 4mg capsules, Lenvatyra 4 capsule, Lenvima generic capsules, Lenvatinib exporter India, Lenvatinib bulk supplier, oral targeted cancer therapy, oncology Lenvatinib capsules, and Lenvatinib manufacturer India.
Manufactured under strict WHO-GMP quality standards, Lenvatyra 4 Capsules ensure consistent potency, accurate dosing, and export-grade blister packaging, making them suitable for global pharmaceutical distribution, hospital oncology supply chains, and international cancer treatment markets.
₹ 4000 / Box Get Latest Price
| Strength | 10 mg |
| Brand | Lenvatyra |
| Capsules per Pack | 10 Capsules |
| Usage | Renal Cancer, Thyroid Cancer, Cancer Care, Liver Cancer |
| Form | Capsule |
| Pack Type | Bottle |
| Manufacturer | Medyra Pharmaceuticals |
Lenvatyra 10 Capsules
Composition: Lenvatinib Capsules 10mg
International Trade Name: Lenvima®
Lenvatyra 10 is a high-quality Lenvatinib 10mg capsule supplied by a trusted pharmaceutical exporter from India. This formulation contains Lenvatinib 10mg, internationally recognized under the brand name Lenvima, and is widely used in targeted therapy for oncology treatment protocols.
Lenvatyra 10 Capsules are primarily indicated for the management of hepatocellular carcinoma, thyroid cancer, and endometrial cancer, either as monotherapy or in combination with other anticancer agents. Lenvatinib is a multikinase inhibitor that targets VEGFR, FGFR, PDGFR, RET, and KIT, inhibiting tumor angiogenesis and cancer cell proliferation.
High-ranking search keywords include Lenvatinib 10mg capsules, Lenvatyra 10 capsule, Lenvima generic capsules, Lenvatinib exporter India, Lenvatinib bulk supplier, oral targeted cancer therapy, oncology Lenvatinib capsules, and Lenvatinib manufacturer India.
Manufactured under strict WHO-GMP quality standards, Lenvatyra 10 Capsules ensure consistent potency, accurate dosing, and export-grade blister packaging, making them suitable for global pharmaceutical distribution, hospital oncology supply chains, and international cancer treatment markets.
₹ 5737.5 / Box Get Latest Price
| Strength | 80 mg |
| Dosage Form | Capsule |
| Brand | Xtandi |
| Units per Pack | 14 Units |
| Usage | Cancer Care, Prostate Cancer |
| Pack Type | Bottle |
| Manufacturer | BDR Pharmaceuticals Internationals Pvt |
Bdenza 80 Capsules
Composition: Enzalutamide Capsules 80mg
International Trade Name: Xtandi®
Bdenza 80 is a high-quality Enzalutamide 80mg Capsule, a generic equivalent of the internationally recognized androgen receptor inhibitor Xtandi. Manufactured in WHO-GMP certified facilities, Bdenza 80 is supplied by trusted pharmaceutical exporters from India to support global oncology and prostate cancer treatment markets.
Enzalutamide is a non-steroidal anti-androgen agent that inhibits androgen receptor signaling, preventing prostate cancer cell growth and proliferation. Bdenza 80 Capsules are primarily used in the treatment of metastatic castration-resistant prostate cancer (mCRPC), either as monotherapy or in combination with androgen deprivation therapy (ADT).
High-ranking search keywords include: Enzalutamide 80mg capsules, Bdenza 80 capsules, Xtandi generic capsules, enzalutamide price, prostate cancer therapy, enzalutamide exporter India, oncology capsule supplier, and anticancer drug manufacturer India.
Bdenza 80 Enzalutamide Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
If you want, I can also:
₹ 16859.92 / Box Get Latest Price
| Strength | 40 mg |
| Dosage Form | Capsule |
| Brand | Xtandi |
| Units per Pack | 28 Units |
| Usage | Cancer Care, Prostate Cancer |
| Pack Type | Blister |
| Manufacturer | BDR Pharmaceuticals Internationals Pvt |
Bdenza 40 Capsules
Composition: Enzalutamide Capsules 40mg
International Trade Name: Xtandi®
Bdenza 40 is a premium-quality Enzalutamide 40mg Capsule, a generic equivalent of the internationally recognized androgen receptor inhibitor Xtandi. Manufactured in WHO-GMP certified facilities, Bdenza 40 is supplied by trusted pharmaceutical exporters from India to support global oncology and prostate cancer treatment markets.
Enzalutamide is a non-steroidal anti-androgen agent that inhibits androgen receptor signaling, preventing prostate cancer cell growth and proliferation. Bdenza 40 Capsules are primarily used in the treatment of metastatic castration-resistant prostate cancer (mCRPC), either as monotherapy or in combination with androgen deprivation therapy (ADT).
High-ranking search keywords include: Enzalutamide 40mg capsules, Bdenza 40 capsules, Xtandi generic capsules, enzalutamide price, prostate cancer therapy, enzalutamide exporter India, oncology capsule supplier, and anticancer drug manufacturer India.
Bdenza 40 Enzalutamide Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
₹ 5906 / Box Get Latest Price
| Strength | 160 mg |
| Dosage Form | Capsule |
| Brand | Bdenza |
| Units per Pack | 7.0 tablets in 1 strip |
| Usage | Cancer Care, Prostate Cancer |
| Pack Type | Strip |
| Manufacturer and | BDR Pharmaceuticals Internationals Pvt |
Bdenza 160 Capsules
Composition: Enzalutamide Capsules 160mg
International Trade Name: Xtandi®
Bdenza 160 is a high-quality Enzalutamide 160mg Capsule, a generic equivalent of the internationally recognized androgen receptor inhibitor Xtandi. Manufactured in WHO-GMP certified facilities, Bdenza 160 is supplied by trusted pharmaceutical exporters from India to support global oncology and prostate cancer treatment markets.
Enzalutamide is a non-steroidal anti-androgen agent that blocks androgen receptor signaling, thereby inhibiting the growth and proliferation of prostate cancer cells. Bdenza 160 Capsules are primarily prescribed for the treatment of metastatic castration-resistant prostate cancer (mCRPC), either as monotherapy or in combination with androgen deprivation therapy (ADT).
High-ranking search keywords include: Enzalutamide 160mg capsules, Bdenza 160 capsules, Xtandi generic capsules, enzalutamide price, prostate cancer therapy, enzalutamide exporter India, oncology capsule supplier, and anticancer drug manufacturer India.
Bdenza 160 Enzalutamide Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are packed in secure, export-grade packaging, making them suitable
₹ 8908 / Bottle Get Latest Price
| Strength | 150 mg |
| Brand | Erlocip |
| Tablets per Pack | 30 Tablets |
| Usage | Lung Cancer, Pancreatic Cancer, Cancer Care |
| Form | Tablet |
| Pack Type | Bottle |
| Manufacturer | Cipla Ltd |
Erlocip 150 Tablets
Composition: Erlotinib Tablets 150mg
International Trade Name: Tarceva®
Erlocip 150 is a high-quality Erlotinib 150mg Tablet, a generic equivalent of the internationally recognized targeted therapy Tarceva. Manufactured in WHO-GMP certified facilities, Erlocip 150 is supplied by trusted pharmaceutical exporters from India to meet global oncology treatment needs.
Erlotinib is a tyrosine kinase inhibitor (EGFR-TKI) that blocks epidermal growth factor receptor signaling, inhibiting tumor cell proliferation. Erlocip 150 Tablets are primarily used in the treatment of non-small cell lung cancer (NSCLC) and advanced pancreatic cancer, either as monotherapy or in combination with chemotherapy.
High-ranking search keywords include: Erlotinib 150mg tablets, Erlocip 150 tablets, Tarceva generic tablets, erlotinib price, EGFR inhibitor therapy, erlotinib exporter India, oncology tablet supplier, and anticancer drug manufacturer India.
Erlocip 150 Erlotinib Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
₹ 1922 / Box Get Latest Price
| Strength | 4 mg |
| Brand | Lenvima |
| Capsules per Pack | 10 Capsules |
| Usage | Renal Cancer, Thyroid Cancer, Liver Cancer, Cancer Care |
| Form | Capsule |
| Pack Type | Blister |
| Manufacture | Cipla Ltd |
Lenvatol 4 Capsules
Composition: Lenvatinib Capsules 4mg
International Trade Name: Lenvima®
Lenvatol 4 is a premium-quality Lenvatinib 4mg Capsule, a generic equivalent of the internationally recognized targeted therapy Lenvima. Manufactured in WHO-GMP certified facilities, Lenvatol 4 is supplied by trusted pharmaceutical exporters from India to support global oncology treatment markets.
Lenvatinib is a multi-kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) and other tyrosine kinases, inhibiting tumor angiogenesis and proliferation. Lenvatol 4 Capsules are widely used in the treatment of hepatocellular carcinoma (HCC), differentiated thyroid cancer (DTC), and endometrial cancer, either as monotherapy or in combination with other targeted therapies.
High-ranking search keywords include: Lenvatinib 4mg capsules, Lenvatol 4 capsules, Lenvima generic capsules, lenvatinib price, multi-kinase inhibitor therapy, lenvatinib exporter India, oncology capsule supplier, and anticancer drug manufacturer India.
Lenvatol 4 Lenvatinib Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
₹ 13120.31 / Box Get Latest Price
| Strength | 100 mg |
| Brand | Lynparza |
| Tablets per Pack | 60 Tablets |
| Usage | Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Cancer Care |
| Form | Tablet |
| Pack Type | Bottle |
| Manufacturer | Zydus Healthcare Limited |
Ibyra 100 Tablets
Composition: Olaparib Tablets 100mg
International Trade Name: Lynparza®
Ibyra 100 is a high-quality Olaparib 100mg Tablet, a generic equivalent of the internationally recognized PARP inhibitor Lynparza. Manufactured in WHO-GMP certified facilities, Ibyra 100 Tablets are supplied by trusted pharmaceutical exporters from India to support global oncology treatment protocols.
Olaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor that disrupts DNA repair mechanisms in cancer cells, leading to cell death, particularly in tumors with BRCA gene mutations. Ibyra 100 Tablets are widely used in the treatment of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer, either as monotherapy or as maintenance therapy following chemotherapy.
High-ranking search keywords include: Olaparib 100mg tablets, Ibyra 100 tablets, Lynparza generic tablets, olaparib price, PARP inhibitor therapy, olaparib exporter India, oncology tablet supplier, and anticancer drug manufacturer India.
Ibyra 100 Olaparib Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, cancer treatment centers, and international pharmaceutical distributors.
₹ 1495.31 / Box Get Latest Price
| Strength | 4 mg |
| Brand | Lenva |
| Capsules per Pack | 10 Capsules |
| Usage | Cancer Care, Renal Cancer, Thyroid Cancer, Liver Cancer |
| Form | Capsule |
| Pack Type | Blister |
| Manufacturer | ZYDUS CADILA |
Lenced 4 Capsules
Composition: Lenvatinib Capsules 4mg
International Trade Name: Lenvima®
Lenced 4 is a high-quality Lenvatinib 4mg Capsule, a generic equivalent of the internationally recognized targeted therapy Lenvima. Manufactured in WHO-GMP certified facilities, Lenced 4 Capsules are supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs.
Lenvatinib is a multi-kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR), fibroblast growth factor receptors (FGFR), and other tyrosine kinases involved in tumor angiogenesis and cancer cell proliferation. Lenced 4 Capsules are widely prescribed for the treatment of hepatocellular carcinoma (HCC), differentiated thyroid cancer (DTC), renal cell carcinoma (in combination therapy), and endometrial cancer.
High-ranking search keywords include: Lenvatinib 4mg capsules, Lenced 4 capsules, Lenvima generic capsules, lenvatinib price, multi-kinase inhibitor therapy, lenvatinib exporter India, oncology capsule supplier, and anticancer drug manufacturer India.
Lenced 4 Lenvatinib Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
₹ 7453.12 / Box Get Latest Price
| Strength | 150 mg |
| Brand | Bracanat |
| Tablets per Pack | 30 Tablets |
| Usage | Breast Cancer, Pancreatic Cancer, Cancer Care, Ovarian Cancer |
| Form | Tablet |
| Pack Type | Bottle |
| Manufacturer | Natco Pharma Ltd |
Bracanat 150 Tablet
Composition: Olaparib Tablets 150mg
International Trade Name: Lynparza®
Bracanat 150 is a high-quality Olaparib 150mg Tablet, a generic equivalent of the internationally recognized PARP inhibitor Lynparza®. Manufactured in WHO-GMP certified facilities, Bracanat 150 Tablets are supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs and targeted cancer therapy needs.
Olaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor that blocks DNA repair pathways, particularly in cancer cells with BRCA1 or BRCA2 mutations, leading to accumulation of DNA damage and selective cancer cell death. Bracanat 150 Tablets are primarily indicated for the treatment of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer, commonly used as maintenance therapy or as monotherapy following platinum-based chemotherapy.
High-ranking search keywords include: Olaparib 150mg tablet, Bracanat 150 tablet, Lynparza generic tablet, olaparib price, PARP inhibitor therapy, BRCA mutation cancer treatment, olaparib exporter India, oncology tablet supplier, and targeted anticancer drug manufacturer India.
Bracanat 150 Olaparib Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for hospital oncology departments, cancer institutes, specialty pharmacies, and international pharmaceutical distributors.
₹ 507.74 / Strip Get Latest Price
| Strength | 15 mg |
| Packaging Size | 10 tablets |
| Brand | Leucorin |
| Composition | Leucovorin Calcium |
| Manufacturer | Samarth Life Sciences Pvt Ltd |
| Form | Tablet |
| Shelf Life | 36 months |
Leucorin 15 mg Tablet
Composition: Calcium Leucovorin 15 mg Tablets
International Trade Name: Leucovorin / Biovorin
Leucorin 15 mg is a premium Calcium Leucovorin tablet supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Calcium Leucovorin 15 mg, a folinic acid derivative internationally recognized under the trade names Leucovorin and Biovorin. It is widely used as rescue therapy in methotrexate-based chemotherapy and as part of combination treatment regimens in colorectal and other cancers.
Leucorin 15 mg tablet, Calcium Leucovorin tablet, Biovorin generic tablets, Leucovorin generic tablets, Calcium Leucovorin exporter India, Leucovorin bulk supplier, oncology Leucovorin tablets, and Calcium Leucovorin manufacturer India.
Manufactured under stringent GMP standards, Leucorin 15 mg ensures consistent quality, precise dosage, and export-grade packaging, making it suitable for global pharmaceutical distribution and oncology markets.
₹ 43212 / Vial Get Latest Price
| Strength | 400 mg |
| Volume | 16 ml |
| Pharmaceutical Form | Injectable Solution |
| Brand | Krabeva |
| Packaging Type | Vial |
| Shelf Life | 36 months |
| Country Of Origin | India |
| Active Ingredient | Bevacizumab |
| Manufacturer | Biocon |
Krabeva 400 mg Injection
Composition: Bevacizumab 400 mg Injection
International Trade Name: Avastin
Krabeva 400 mg is a premium Bevacizumab injection supplied by Shivanta Impex, a trusted pharmaceutical exporter from India. This formulation contains Bevacizumab 400 mg, a monoclonal antibody internationally recognized under the brand name Avastin, widely used in targeted therapy for colorectal cancer, lung cancer, renal cell carcinoma, glioblastoma, and other solid tumors.
Krabeva 400 mg injection, Bevacizumab 400 mg injection, Avastin generic injection, Bevacizumab exporter India, Bevacizumab bulk supplier, oncology Bevacizumab injection, and Bevacizumab manufacturer India.
Manufactured under stringent GMP standards, Krabeva 400 mg ensures consistent quality, accurate concentration, and sterile, export-grade packaging, making it suitable for global pharmaceutical distribution and oncology markets.
₹ 2350 / Bottle Get Latest Price
| Strength | 200 mg |
| Packaging Size | 30 tablets |
| Brand | Nexavar |
| Manufacturer | Medyra Pharmaceuticals |
| Composition | Sorafenib |
| Form | Tablet |
| Indication | Liver Cancer, Renal Cell Carcinoma, Thyroid Cancer |
| Shelf Life | 36 months |
| Country of Origin | India |
Sorafyra 200 Tablets
Composition: Sorafenib Tablets 200mg
International Trade Name: Nexavar®
Sorafyra 200 is a high-quality Sorafenib 200mg Tablet, a generic equivalent of the internationally recognized targeted therapy Nexavar. Manufactured in WHO-GMP certified facilities, Sorafyra 200 is supplied by trusted pharmaceutical exporters from India to serve global oncology and specialty medicine markets.
Sorafenib is a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis by inhibiting multiple intracellular and cell surface kinases. Sorafyra 200 Tablets are widely used in the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and differentiated thyroid carcinoma, either as monotherapy or as part of targeted cancer treatment protocols.
High-ranking search keywords include: Sorafenib 200mg tablets, Sorafyra 200 tablets, Nexavar generic tablets, sorafenib price, multikinase inhibitor therapy, sorafenib exporter India, liver cancer targeted therapy, and oncology tablet manufacturer India.
Sorafyra 200 Sorafenib Tablets are produced under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term product stability. The tablets are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
₹ 4900 / Box Get Latest Price
| Strength | 12.5 mg |
| Brand | Sunityra |
| Packaging Size | 28 Capsules |
| Form | Capsule |
| Dose Type | Oral |
| Pack Type | Bottle |
| Shelf Life | 36 Months |
| Manuifacturer | Medyra Pharmaceutical |
Sunityra 12.5 Capsules
Composition: Sunitinib Malate Capsules 12.5mg
International Trade Name: Sutent®
Sunityra 12.5 is a premium-quality Sunitinib Malate 12.5mg Capsule, a generic equivalent of the internationally recognized targeted therapy Sutent. Manufactured in WHO-GMP certified facilities, Sunityra 12.5 is supplied by trusted pharmaceutical exporters from India to meet the needs of global oncology and specialty medicine markets.
Sunitinib is a multitargeted receptor tyrosine kinase inhibitor that blocks pathways involved in tumor growth and angiogenesis. Sunityra 12.5 Capsules are widely prescribed in the treatment of gastrointestinal stromal tumors (GIST), advanced renal cell carcinoma (RCC), and pancreatic neuroendocrine tumors (pNET).
High-ranking search keywords include: Sunitinib malate 12.5mg capsules, Sunityra 12.5 capsules, Sutent generic capsules, sunitinib price, tyrosine kinase inhibitor therapy, sunitinib exporter India, kidney cancer targeted therapy, and oncology capsule manufacturer India.
Sunityra 12.5 Sunitinib Malate Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and product stability. The capsules are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
₹ 1500 / Box Get Latest Price
| Strength | 100 mg |
| Brand | Ninbrosis |
| Capsules per Pack | 10 Capsules |
| Usage | Lung Cancer, IPF, ILD |
| Form | Capsule |
| Pack Type | Blister |
| Manufacturer | Healing Pharma |
Ninbrosis 100 Soft Gelatin Capsule
Composition: Nintedanib Soft Gelatin Capsules 100mg
International Trade Name: Ofev® / Vargatef®
Ninbrosis 100 is a high-quality Nintedanib 100mg Soft Gelatin Capsule, a generic equivalent of the internationally recognized tyrosine kinase inhibitor marketed as Ofev® and Vargatef®. Manufactured in WHO-GMP certified facilities, Ninbrosis 100 Capsules are supplied by trusted pharmaceutical exporters from India to support global pulmonology and oncology treatment programs.
Nintedanib is a small-molecule tyrosine kinase inhibitor that targets multiple growth factor receptors, including VEGFR, FGFR, and PDGFR, thereby inhibiting pathways involved in fibrosis progression and tumor angiogenesis. Ninbrosis 100 Capsules are primarily indicated for the treatment of idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, and non-small cell lung cancer (NSCLC) in specific clinical settings.
High-ranking search keywords include: Nintedanib 100mg capsule, Ninbrosis 100 capsule, Ofev generic capsule, Vargatef generic capsule, nintedanib price, idiopathic pulmonary fibrosis treatment, ILD therapy, nintedanib exporter India, and tyrosine kinase inhibitor capsule supplier.
Ninbrosis 100 Nintedanib Soft Gelatin Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for pulmonology clinics, oncology centers, specialty pharmacies, and international pharmaceutical distributors.
₹ 28305.94 / Bottle Get Latest Price
| Strength | 500 mg |
| Brand | Abiranamo |
| Tablets per Pack | 60 Tablets |
| Pack Type | Bottle |
| Usage | Cancer Care, Prostate Cancer |
| Form | Tablet |
| Release Type | Film Coated |
Abiranamo 500mg Tablet
Composition: Abiraterone Acetate Tablets 500mg
International Trade Name: Zytiga®
Abiranamo 500 is a high-quality Abiraterone Acetate 500mg Tablet, a generic equivalent of the internationally recognized androgen biosynthesis inhibitor Zytiga®. Manufactured in WHO-GMP certified facilities, Abiranamo 500 Tablets are supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs and advanced prostate cancer therapy requirements.
Abiraterone acetate is a selective CYP17 inhibitor that suppresses androgen production in the testes, adrenal glands, and prostate tumor tissue, resulting in reduced androgen levels and inhibition of prostate cancer cell growth. Abiranamo 500 Tablets are primarily indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC), administered in combination with prednisone or prednisolone.
High-ranking search keywords include: Abiraterone acetate 500mg tablet, Abiranamo 500 tablet, Zytiga generic tablet, abiraterone price, prostate cancer hormone therapy, CYP17 inhibitor treatment, abiraterone exporter India, oncology tablet supplier, and targeted anticancer drug manufacturer India.
Abiranamo 500 Abiraterone Acetate Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for hospital oncology departments, cancer institutes, specialty pharmacies, and international pharmaceutical distributors.
₹ 27000 / Box Get Latest Price
| Strength | 150 mg |
| Brand | Olapyra |
| Tablets per Pack | 60 Tablets |
| Usage | Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Cancer Care |
| Form | Tablet |
| Pack Type | Bottle |
| Manufacturer | Medyra Pharmacueticals |
Olapyra 150 Tablets
Composition: Olaparib Tablets 150mg
International Trade Name: Lynparza®
Olapyra 150 is a high-quality Olaparib 150mg Tablet, a generic equivalent of the internationally renowned targeted therapy Lynparza. Manufactured in WHO-GMP certified facilities, Olapyra 150 is supplied by trusted pharmaceutical exporters from India to meet the needs of global oncology treatment markets.
Olaparib is a PARP (poly ADP-ribose polymerase) inhibitor that works by preventing DNA repair in cancer cells, leading to selective cancer cell death. Olapyra 150 Tablets are widely used in the treatment of ovarian cancer, breast cancer (BRCA-mutated), prostate cancer, and pancreatic cancer, particularly in patients with specific genetic mutations.
High-ranking search keywords include: Olaparib 150mg tablets, Olapyra 150 tablets, Lynparza generic tablets, olaparib price, PARP inhibitor therapy, olaparib exporter India, targeted cancer therapy supplier, and oncology tablet manufacturer India.
Olapyra 150 Olaparib Tablets are produced under strict quality control and GMP standards, ensuring consistent potency, accurate dosing, and stability. The tablets are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
₹ 5624.06 / Bottle Get Latest Price
| Strength | 500 mg |
| Brand | Abiratred |
| Tablets per Pack | 60 Tablets |
| Pack Type | Bottle |
| Usage | Prostate Cancer, Cancer Care |
| Form | Tablet |
| Release Type | Film Coated |
Abiratred 500mg Tablet
Composition: Abiraterone Acetate Tablets 500mg
International Trade Name: Zytiga®
Abiratred 500 is a high-quality Abiraterone Acetate 500mg Tablet, a generic equivalent of the internationally recognized androgen biosynthesis inhibitor Zytiga®. Manufactured in WHO-GMP certified facilities, Abiratred 500 Tablets are supplied by trusted pharmaceutical exporters from India to support global oncology treatment programs and advanced prostate cancer therapy requirements.
Abiraterone acetate is a selective CYP17 inhibitor that suppresses androgen production in the testes, adrenal glands, and prostate tumor tissue, leading to reduced androgen levels and inhibition of prostate cancer cell growth. Abiratred 500 Tablets are primarily indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC), in combination with prednisone or prednisolone.
High-ranking search keywords include: Abiraterone acetate 500mg tablet, Abiratred 500 tablet, Zytiga generic tablet, abiraterone price, prostate cancer hormone therapy, CYP17 inhibitor treatment, abiraterone exporter India, oncology tablet supplier, and targeted anticancer drug manufacturer India.
Abiratred 500 Abiraterone Acetate Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are supplied in secure, export-grade packaging with appropriate regulatory documentation, making them suitable for hospital oncology departments, cancer institutes, specialty pharmacies, and international pharmaceutical distributors.
₹ 1652 / Bottle Get Latest Price
| Strength | 10 mg |
| Brand | Lidomyra |
| Capsules per Pack | 10 Capsules |
| Usage | MDS, Lymphoma, Cancer Care, Multiple Myeloma |
| Form | Capsule |
| Pack Type | Bottle |
| Manufacture | Medyra Pharmaceuticals |
Lidomyra 10 Capsules
Composition: Lenalidomide Capsules 10mg
International Trade Name: Revlimid®
Lidomyra 10 is a high-quality Lenalidomide 10mg capsule supplied by a trusted pharmaceutical exporter from India. This formulation contains Lenalidomide 10mg, internationally recognized under the brand name Revlimid, and is widely used in hematology and oncology treatment protocols.
Lidomyra 10 Capsules are primarily indicated for the management of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma, either as monotherapy or in combination with other chemotherapeutic agents. Lenalidomide is an immunomodulatory agent that inhibits cancer cell proliferation, enhances immune response, and suppresses angiogenesis.
High-ranking search keywords include Lenalidomide 10mg capsules, Lidomyra 10 capsule, Revlimid generic capsules, Lenalidomide exporter India, Lenalidomide bulk supplier, oral hematology medicine, oncology Lenalidomide capsules, and Lenalidomide manufacturer India.
Manufactured under strict WHO-GMP quality standards, Lidomyra 10 Capsules ensure consistent potency, accurate dosing, and secure export-grade blister packaging, making them suitable for global pharmaceutical distribution, hospital hematology supply chains, and international cancer treatment markets.
₹ 3660 / Bottle Get Latest Price
| Strength | 25 mg |
| Brand | Lidomyra |
| Capsules per Pack | 10 Capsules |
| Usage | Multiple Myeloma, Lymphoma, Cancer Care, MDS |
| Form | Capsule |
| Pack Type | Bottle |
| Manufacturer | Medyra Pharmacueticals |
Lidomyra 25 Capsules
Composition: Lenalidomide Capsules 25mg
International Trade Name: Revlimid®
Lidomyra 25 is a high-quality Lenalidomide 25mg capsule supplied by a trusted pharmaceutical exporter from India. This formulation contains Lenalidomide 25mg, internationally recognized under the brand name Revlimid, and is widely used in hematology and oncology treatment protocols.
Lidomyra 25 Capsules are primarily indicated for the management of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma, either as monotherapy or in combination with other chemotherapeutic agents. Lenalidomide is an immunomodulatory agent that inhibits cancer cell proliferation, enhances immune response, and suppresses angiogenesis.
High-ranking search keywords include Lenalidomide 25mg capsules, Lidomyra 25 capsule, Revlimid generic capsules, Lenalidomide exporter India, Lenalidomide bulk supplier, oral hematology medicine, oncology Lenalidomide capsules, and Lenalidomide manufacturer India.
Manufactured under strict WHO-GMP quality standards, Lidomyra 25 Capsules ensure consistent potency, accurate dosing, and secure export-grade blister packaging, making them suitable for global pharmaceutical distribution, hospital hematology supply chains, and international cancer treatment markets.
₹ 89 / Vial Get Latest Price
| Pharmacopoeial Standard | IP |
| Brand | Metyra |
| Packaging Size | 2 ml |
| Strength | 50 mg |
| Treatment | Rheumatoid Arthritis |
| Shelf Life | 36 months |
| Packaging Type | Vial |
| Usage/Application | Personal |
| Composition | Methotrexate |
Metyra 50 Injection
Composition: Methotrexate Injection 50mg
International Trade Name: Rheumatrex®
Metyra 50 is a high-quality Methotrexate 50mg injection supplied by a trusted pharmaceutical exporter from India. This formulation contains Methotrexate 50mg, internationally recognized under the brand name Rheumatrex, and is widely used in oncology, rheumatology, and immunology treatment protocols.
Metyra 50 Injection is commonly indicated for the treatment of acute lymphoblastic leukemia (ALL), lymphomas, osteosarcoma, and other malignancies. It is also used in lower doses for rheumatoid arthritis, psoriasis, and certain autoimmune disorders. Methotrexate is an antimetabolite and antifolate agent that inhibits DNA synthesis, repair, and cellular replication.
High-ranking search keywords include Methotrexate 50mg injection, Metyra 50 injection, Rheumatrex generic injection, Methotrexate exporter India, Methotrexate bulk supplier, injectable chemotherapy drugs, oncology Methotrexate injection, and Methotrexate manufacturer India.
Manufactured under strict WHO-GMP quality standards, Metyra 50 Injection ensures consistent potency, precise dosing, and export-grade sterile packaging, making it suitable for global pharmaceutical distribution, hospital oncology supply chains, and international cancer and specialty treatment markets.
₹ 1120 / Vial Get Latest Price
| Pharmacopoeial Standard | IP |
| Brand | Metyra |
| Packaging Size | 20 ml |
| Strength | 500 mg |
| Treatment | Cancer |
| Storage Condition | Store Below 25 Degree C |
| Shelf Life | 36 months |
| Packaging Type | Vial |
| Usage/Application | Personal |
| Composition | Methotrexate |
Metyra 500 Injection
Composition: Methotrexate Injection 500mg
International Trade Name: Rheumatrex®
Metyra 500 is a high-quality Methotrexate 500mg injection supplied by a trusted pharmaceutical exporter from India. This formulation contains Methotrexate 500mg, internationally recognized under the brand name Rheumatrex, and is widely used in high-dose oncology treatment protocols.
Metyra 500 Injection is commonly indicated for the treatment of osteosarcoma, acute lymphoblastic leukemia (ALL), non-Hodgkin’s lymphoma, and other malignancies requiring high-dose methotrexate therapy with appropriate leucovorin rescue. Methotrexate is an antimetabolite and antifolate agent that inhibits DNA synthesis, repair, and cellular replication.
High-ranking search keywords include Methotrexate 500mg injection, Metyra 500 injection, Rheumatrex generic injection, Methotrexate exporter India, Methotrexate bulk supplier, high-dose Methotrexate injection, injectable chemotherapy drugs, oncology Methotrexate injection, and Methotrexate manufacturer India.
Manufactured under strict WHO-GMP quality standards, Metyra 500 Injection ensures consistent potency, precise dosing, and export-grade sterile packaging, making it suitable for global pharmaceutical distribution, hospital oncology supply chains, and international cancer treatment markets.
₹ 450 / Strip Get Latest Price
| Strength | 40 mg |
| Brand | Megestyra 40 Tablets Composition: Megestrol Acetate Tablets 40mg International Trade Name: Megace® |
| Pack Type | Strip |
| Tablets per Pack | 10 Tablets |
| Form | Tablet |
| Usage | Cancer Care |
| Manufacturer | Medyra Pharmacueticals |
Megestyra 40 Tablets
Composition: Megestrol Acetate Tablets 40mg
International Trade Name: Megace®
Megestyra 40 is a high-quality Megestrol Acetate 40mg tablet supplied by a trusted pharmaceutical exporter from India. This formulation contains Megestrol Acetate 40mg, internationally recognized under the brand name Megace, and is widely used in oncology and supportive care treatment protocols.
Megestyra 40 Tablets are primarily indicated for the management of anorexia, cachexia, and unexplained weight loss in patients with cancer or AIDS, and are also used in the treatment of advanced breast cancer and endometrial cancer. Megestrol Acetate is a progestational agent that helps stimulate appetite and modulate hormonal pathways.
High-ranking search keywords include Megestrol Acetate 40mg tablets, Megestyra 40 tablet, Megace generic tablets, Megestrol exporter India, Megestrol bulk supplier, appetite stimulant tablets, oncology supportive care medicine, and Megestrol Acetate manufacturer India.
Manufactured under strict WHO-GMP quality standards, Megestyra 40 Tablets ensure consistent potency, accurate dosing, and secure export-grade blister packaging, making them suitable for global pharmaceutical distribution, hospital pharmacies, and international oncology and supportive care markets.
₹ 1320 / Strip Get Latest Price
| Strength | 160 mg |
| Brand | Megestyra |
| Pack Type | Strip |
| Tablets per Pack | 10 Tablets |
| Form | Tablet |
| Usage | Cancer Care |
| Manufacturer | Medyra Pharmacueticals |
Megestyra 160 Tablets
Composition: Megestrol Acetate Tablets 160mg
International Trade Name: Megace®
Megestyra 160 is a high-quality Megestrol Acetate 160mg tablet supplied by a trusted pharmaceutical exporter from India. This formulation contains Megestrol Acetate 160mg, internationally recognized under the brand name Megace, and is widely used in oncology and supportive care treatment protocols.
Megestyra 160 Tablets are primarily indicated for the management of cancer- and AIDS-related cachexia, anorexia, and significant unintentional weight loss, and are also used in the treatment of advanced breast cancer and endometrial carcinoma. Megestrol Acetate is a progestational agent that helps stimulate appetite and modulate hormonal activity.
High-ranking search keywords include Megestrol Acetate 160mg tablets, Megestyra 160 tablet, Megace generic tablets, Megestrol exporter India, Megestrol bulk supplier, appetite stimulant tablets, oncology supportive care medicines, and Megestrol Acetate manufacturer India.
Manufactured under strict WHO-GMP quality standards, Megestyra 160 Tablets ensure consistent potency, precise dosing, and secure export-grade blister packaging, making them suitable for global pharmaceutical distribution, hospital pharmacies, and international oncology and supportive care markets.
₹ 4029 / Vial Get Latest Price
| Formulation Type | Infusion |
| Brand | Taxyra |
| Pharmacopoeia Standard | IP |
| Strength | 100 mg |
| Packaging Size | 16.7 ml |
| Shelf Life | 36 months |
| Storage Temperature | 20-25 degree c |
| Usages | Breast Cancer |
| Packaging Type | Vial |
| Composition | Paclitaxel |
Taxyra 100 Injection
Composition: Paclitaxel Injection 100mg
International Trade Name: Taxol®
Taxyra 100 is a high-quality Paclitaxel 100mg Injection, a generic equivalent of Taxol, widely used in chemotherapy regimens for the treatment of multiple solid tumors. It is manufactured under WHO-GMP compliant facilities and supplied by reliable pharmaceutical exporters from India for regulated and semi-regulated international markets.
Paclitaxel is a taxane class antineoplastic agent that works by stabilizing microtubules and inhibiting cell division, leading to cancer cell death. Taxyra 100 Injection is commonly indicated for the treatment of ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC), Kaposi’s sarcoma, and other advanced malignancies, either as monotherapy or in combination chemotherapy protocols.
Key SEO search terms include: Paclitaxel injection 100mg, Taxyra 100 injection, Taxol generic injection, paclitaxel price, paclitaxel chemotherapy, paclitaxel exporter India, oncology injections supplier, and anticancer drug manufacturer India.
Taxyra 100 Paclitaxel Injection is supplied in secure, export-grade vial packaging, ensuring product stability, sterility, and compliance with international shipping standards. It is suitable for hospital oncology departments, cancer treatment centers, and global pharmaceutical distributors.
₹ 10400 / Vial Get Latest Price
| Formulation Type | Infusion |
| Brand | Taxyra |
| Pharmacopoeia Standard | IP |
| Packaging Size | 43.4 ml |
| Shelf Life | 36 months |
| Storage Temperature | 20-25 degree c |
| Usages | Breast Cancer |
| Packaging Type | Vial |
| Composition | Paclitaxel |
| Manufacturer | Medyra Pharmacueticals |
| Strength | 260 mg |
Taxyra 260 Injection
Composition: Paclitaxel Injection 260mg
International Trade Name: Taxol®
Taxyra 260 is a premium-quality Paclitaxel 260mg Injection, a generic equivalent of the internationally recognized chemotherapy drug Taxol. Manufactured in WHO-GMP certified facilities, Taxyra 260 is supplied by trusted pharmaceutical exporters from India to meet the demands of global oncology supply chains.
Paclitaxel is a taxane-based anticancer agent that inhibits cancer cell division by stabilizing microtubules, thereby preventing tumor growth and proliferation. Taxyra 260 Injection is widely prescribed in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), pancreatic cancer, and AIDS-related Kaposi’s sarcoma, either alone or in combination with other chemotherapy agents.
High-ranking search keywords include: Paclitaxel injection 260mg, Taxyra 260 injection, Taxol 260mg generic, paclitaxel chemotherapy injection, paclitaxel price, paclitaxel exporter India, oncology injectable supplier, and anticancer drug manufacturer India.
Taxyra 260 Paclitaxel Injection is packed in sterile, export-grade glass vials to ensure maximum stability, safety, and compliance with international pharmaceutical transport regulations. It is suitable for hospital oncology units, cancer treatment centers, and international pharmaceutical distributors.
₹ 12000 / Vial Get Latest Price
| Formulation Type | Infusion |
| Brand | Taxyra |
| Pharmacopoeia Standard | IP |
| Packaging Size | 50 ml |
| Shelf Life | 36 months |
| Storage Temperature | 20-25 degree c |
| Usages | Breast Cancer |
| Packaging Type | Vial |
| Composition | Paclitaxel |
| Strength | 300 mg |
Taxyra 300 Injection
Composition: Paclitaxel Injection 300mg
International Trade Name: Taxol®
Taxyra 300 is a high-quality Paclitaxel 300mg Injection, a generic version of the globally trusted chemotherapy brand Taxol. Manufactured in WHO-GMP certified facilities, Taxyra 300 is supplied by leading pharmaceutical exporters from India, ensuring reliable quality for international oncology markets.
Paclitaxel is a taxane-class antineoplastic agent that works by stabilizing microtubules and inhibiting mitosis, leading to effective cancer cell death. Taxyra 300 Injection is commonly used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), pancreatic cancer, and AIDS-related Kaposi’s sarcoma, either as monotherapy or in combination chemotherapy regimens.
High-ranking SEO keywords include: Paclitaxel injection 300mg, Taxyra 300 injection, Taxol generic injection, paclitaxel chemotherapy, paclitaxel price, paclitaxel exporter India, oncology injectable supplier, and anticancer drug manufacturer India.
Taxyra 300 Paclitaxel Injection is supplied in sterile, export-grade vial packaging, ensuring product stability, safety, and compliance with global pharmaceutical transportation standards. It is suitable for hospital oncology departments, cancer treatment centers, and international pharmaceutical distributors.
₹ 1000 / Vial Get Latest Price
| Strength | 100 mg |
| Vial Volume | 50 ml |
| Company | Medyra Pharmaceuticals |
| Form | Infusion Only |
| Packaging Type | Vial |
| Shelf Life | 36 months |
| Usage | Gastric cancer, Colorectal cancer |
| Storage | 2–8°C |
Oxalyra 100 Injection
Composition: Oxaliplatin Injection 100mg
International Trade Name: Eloxatin®
Oxalyra 100 is a premium-quality Oxaliplatin 100mg Injection, a generic equivalent of the globally recognized chemotherapy drug Eloxatin. Manufactured in WHO-GMP certified facilities, Oxalyra 100 is supplied by trusted pharmaceutical exporters from India, meeting the quality requirements of regulated and semi-regulated oncology markets worldwide.
Oxaliplatin is a platinum-based antineoplastic agent that interferes with DNA replication and transcription, leading to apoptosis of cancer cells. Oxalyra 100 Injection is widely used in the treatment of colorectal cancer, particularly in combination chemotherapy regimens such as FOLFOX, and is also indicated for other gastrointestinal malignancies.
High-ranking search keywords include: Oxaliplatin injection 100mg, Oxalyra 100 injection, Eloxatin generic injection, oxaliplatin chemotherapy, oxaliplatin price, oxaliplatin exporter India, oncology injectable supplier, and anticancer drug manufacturer India.
Oxalyra 100 Oxaliplatin Injection is packed in sterile, export-grade vials, ensuring product stability, accurate dosing, and compliance with international pharmaceutical shipping standards. It is suitable for hospital oncology departments, cancer treatment centers, and global pharmaceutical distributors.
₹ 2345 / Vial Get Latest Price
| Strength | 50 mg |
| Vial Volume | 25 ml |
| Company | Medyra Pharmacueticals |
| Form | Infusion |
| Packaging Type | Vial |
| Shelf Life | 36 months |
| Usage | Gastric cancer, Colorectal cancer |
| Storage | 2–8°C |
Oxalyra 50 Injection
Composition: Oxaliplatin Injection 50mg
International Trade Name: Eloxatin®
Oxalyra 50 is a premium-quality Oxaliplatin 50mg Injection, a generic equivalent of the globally recognized chemotherapy drug Eloxatin. Manufactured in WHO-GMP certified facilities, Oxalyra 50 is supplied by trusted pharmaceutical exporters from India to serve regulated and semi-regulated oncology markets worldwide.
Oxaliplatin is a platinum-based antineoplastic agent that disrupts DNA replication by forming cross-links within cancer cells, resulting in apoptosis. Oxalyra 50 Injection is widely used in the treatment of colorectal cancer, particularly in combination chemotherapy protocols such as FOLFOX, and is also indicated for other gastrointestinal malignancies.
High-ranking search keywords include: Oxaliplatin injection 50mg, Oxalyra 50 injection, Eloxatin generic injection, oxaliplatin chemotherapy, oxaliplatin price, oxaliplatin exporter India, oncology injectable supplier, and anticancer drug manufacturer India.
Oxalyra 50 Oxaliplatin Injection is supplied in sterile, export-grade vials, ensuring accurate dosage, product stability, and full compliance with international pharmaceutical transport and storage standards. It is suitable for hospital oncology departments, cancer treatment centers, and global pharmaceutical distributors.
₹ 8100 / Vial Get Latest Price
| Dosage Form | Injection |
| Strength | 100 mg |
| Treatment | Non-Small Cell Lung Cancer |
| Manufacturer | Medyra |
| Brand Name | Pemetyra |
| Pharmacopoeia Standard | IP |
| Shelf Life | 36 months |
| Storage Temperature | 2-8 degree c |
| Composition | Pemetrexed |
Pemetyra 100 Injection
Composition: Pemetrexed Injection 100mg
International Trade Name: Alimta®
Pemetyra 100 is a high-quality Pemetrexed 100mg Injection, a generic equivalent of the globally recognized chemotherapy drug Alimta. Manufactured in WHO-GMP certified facilities, Pemetyra 100 is supplied by trusted pharmaceutical exporters from India to meet the requirements of international oncology markets.
Pemetrexed is a multi-targeted antifolate antineoplastic agent that inhibits key enzymes involved in DNA and RNA synthesis, leading to cancer cell death. Pemetyra 100 Injection is widely used in the treatment of malignant pleural mesothelioma and non-small cell lung cancer (NSCLC), either as monotherapy or in combination with cisplatin.
High-ranking search keywords include: Pemetrexed injection 100mg, Pemetyra 100 injection, Alimta generic injection, pemetrexed chemotherapy, pemetrexed price, pemetrexed exporter India, oncology injectable supplier, and anticancer drug manufacturer India.
Pemetyra 100 Pemetrexed Injection is supplied in sterile, export-grade vials, ensuring accurate dosage, product stability, and full compliance with international pharmaceutical transport and storage standards. It is suitable for hospital oncology departments, cancer treatment centers, and global pharmaceutical distributors.
₹ 1900 / Vial Get Latest Price
| Dosage Form | Injection |
| Strength | 500 mg |
| Treatment | Non-Small Cell Lung Cancer |
| Manufacturer | Medyra Pharmaceuticals |
| Brand Name | Pemetyra |
| Pharmacopoeia Standard | IP |
| Shelf Life | 36 months |
| Storage Temperature | 2-8 degree c |
| Composition | Pemetrexed |
Pemetyra 500 Injection
Composition: Pemetrexed Injection 500mg
International Trade Name: Alimta®
Pemetyra 500 is a premium-quality Pemetrexed 500mg Injection, a generic equivalent of the internationally recognized chemotherapy drug Alimta. Manufactured in WHO-GMP certified facilities, Pemetyra 500 is supplied by trusted pharmaceutical exporters from India to support global oncology treatment requirements.
Pemetrexed is a multi-targeted antifolate antineoplastic agent that inhibits essential enzymes involved in DNA and RNA synthesis, leading to effective cancer cell death. Pemetyra 500 Injection is widely used in the treatment of non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma, either as monotherapy or in combination with cisplatin-based chemotherapy regimens.
High-ranking search keywords include: Pemetrexed injection 500mg, Pemetyra 500 injection, Alimta generic injection, pemetrexed chemotherapy, pemetrexed price, pemetrexed exporter India, oncology injectable supplier, and anticancer drug manufacturer India.
Pemetyra 500 Pemetrexed Injection is supplied in sterile, export-grade vial packaging, ensuring accurate dosing, product stability, and compliance with international pharmaceutical storage and transport standards. It is suitable for hospital oncology departments, cancer treatment centers, and international pharmaceutical distributors.
₹ 11610 / Bottle Get Latest Price
| Strength | 75 mg |
| Brand | Ibrance |
| Capsules per Pack | 21 Capsules |
| Usage | Breast Cancer, Cancer Care |
| Form | Capsule |
| Pack Type | Bottle |
| Manufacturer | Medyra Pharmaceutical |
Palbomyra 75 Capsules
Composition: Palbociclib Capsules 75mg
International Trade Name: Ibrance®
Palbomyra 75 is a high-quality Palbociclib 75mg Capsule, a generic equivalent of the internationally renowned targeted therapy Ibrance. Manufactured in WHO-GMP certified facilities, Palbomyra 75 is supplied by trusted pharmaceutical exporters from India to meet the requirements of global oncology and specialty medicine markets.
Palbociclib is a CDK4/6 inhibitor that works by blocking proteins responsible for cell cycle progression, thereby inhibiting the proliferation of cancer cells. Palbomyra 75 Capsules are widely used in combination with endocrine therapy for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in adult patients.
High-ranking search keywords include: Palbociclib 75mg capsules, Palbomyra 75 capsules, Ibrance generic capsules, palbociclib price, CDK4/6 inhibitor therapy, palbociclib exporter India, breast cancer targeted therapy, and oncology capsule manufacturer India.
Palbomyra 75 Palbociclib Capsules are produced under strict GMP quality standards, ensuring consistent potency, accurate dosing, and product stability. The capsules are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
₹ 14400 / Bottle Get Latest Price
| Strength | 125 mg |
| Brand | Palbomyra |
| Capsules per Pack | 21 Capsules |
| Usage | Breast Cancer, Cancer Care |
| Form | Capsule |
| Pack Type | Bottle |
| Manufacturer | Medyra Pharmacueticals |
Palbomyra 125 Capsules
Composition: Palbociclib Capsules 125mg
International Trade Name: Ibrance®
Palbomyra 125 is a premium-quality Palbociclib 125mg Capsule, a generic equivalent of the globally recognized targeted breast cancer therapy Ibrance. Manufactured in WHO-GMP certified facilities, Palbomyra 125 is supplied by trusted pharmaceutical exporters from India to support international oncology treatment and specialty medicine markets.
Palbociclib is a CDK4/6 inhibitor that selectively blocks cyclin-dependent kinases 4 and 6, preventing cell cycle progression and inhibiting cancer cell proliferation. Palbomyra 125 Capsules are widely prescribed in combination with endocrine therapy for the treatment of hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer in adult patients.
High-ranking search keywords include: Palbociclib 125mg capsules, Palbomyra 125 capsules, Ibrance generic capsules, palbociclib price, CDK4/6 inhibitor therapy, palbociclib exporter India, breast cancer targeted therapy, and oncology capsule manufacturer India.
Palbomyra 125 Palbociclib Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term product stability. The capsules are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and global pharmaceutical distributors.
₹ 8448 / Bottle Get Latest Price
| Strength | 100 mg |
| Brand | Tamozyra |
| Capsules per Pack | 5 Capsules |
| Pack Type | Bottle |
| Form | Capsule |
| Usage | Cancer Care, Brain Tumor |
| Manufacturer | Medyra Pharmaceutical |
Composition: Temozolomide Capsules 100mg
International Trade Name: Temodar®
Tamozyra 100 is a premium-quality Temozolomide 100mg Capsule, a generic equivalent of the globally recognized chemotherapy drug Temodar. Manufactured in WHO-GMP certified facilities, Tamozyra 100 is supplied by trusted pharmaceutical exporters from India to support international oncology treatment and specialty medicine markets.
Temozolomide is an oral alkylating antineoplastic agent that works by damaging DNA in rapidly dividing cancer cells, leading to apoptosis. Tamozyra 100 Capsules are widely used in the treatment of glioblastoma multiforme (GBM) and anaplastic astrocytoma, either as monotherapy or in combination with radiotherapy.
High-ranking search keywords include: Temozolomide 100mg capsules, Tamozyra 100 capsules, Temodar generic capsules, temozolomide price, brain cancer chemotherapy, temozolomide exporter India, oncology capsule supplier, and anticancer drug manufacturer India.
₹ 1885 / Bottle Get Latest Price
| Strength | 20 mg |
| Brand | Tamozyra |
| Capsules per Pack | 5 Capsules |
| Pack Type | Bottle |
| Form | Capsule |
| Usage | Brain Tumor, Cancer Care |
| Manufacturer | Medyra Pharmaceuticals |
Tamozyra 20 Capsules
Composition: Temozolomide Capsules 20mg
International Trade Name: Temodar®
Tamozyra 20 is a high-quality Temozolomide 20mg Capsule, a generic equivalent of the internationally recognized chemotherapy drug Temodar. Manufactured in WHO-GMP certified facilities, Tamozyra 20 is supplied by trusted pharmaceutical exporters from India to meet global oncology treatment requirements.
Temozolomide is an oral alkylating antineoplastic agent that damages DNA in rapidly dividing cancer cells, leading to apoptosis. Tamozyra 20 Capsules are widely used in the treatment of glioblastoma multiforme (GBM) and anaplastic astrocytoma, either as monotherapy or in combination with radiotherapy.
High-ranking search keywords include: Temozolomide 20mg capsules, Tamozyra 20 capsules, Temodar generic capsules, temozolomide price, brain cancer chemotherapy, temozolomide exporter India, oncology capsule supplier, and anticancer drug manufacturer India.
Tamozyra 20 Temozolomide Capsules are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The capsules are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and international pharmaceutical distributors.
₹ 21000 / Bottle Get Latest Price
| Strength | 250 mg |
| Brand | Tamozyra |
| Capsules per Pack | 5 Capsules |
| Pack Type | Bottle |
| Form | Capsule |
| Usage | Brain Tumor, Cancer Care |
| Manufacturer | Medyra Pharmaceutical |
Tamozyra 250 Capsules
Composition: Temozolomide Capsules 250mg
International Trade Name: Temodar®
Tamozyra 250 is a premium-quality Temozolomide 250mg Capsule, a generic equivalent of the globally recognized chemotherapy drug Temodar. Manufactured in WHO-GMP certified facilities, Tamozyra 250 is supplied by trusted pharmaceutical exporters from India to support international oncology treatment and specialty medicine markets.
Temozolomide is an oral alkylating antineoplastic agent that works by damaging DNA in rapidly dividing cancer cells, leading to apoptosis. Tamozyra 250 Capsules are widely used in the treatment of glioblastoma multiforme (GBM) and anaplastic astrocytoma, either as monotherapy or in combination with radiotherapy.
High-ranking search keywords include: Temozolomide 250mg capsules, Tamozyra 250 capsules, Temodar generic capsules, temozolomide price, brain cancer chemotherapy, temozolomide exporter India, oncology capsule supplier, and anticancer drug manufacturer India.
Tamozyra 250 Temozolomide Capsules are manufactured under stringent GMP quality standards, ensuring consistent potency, accurate dosing, and long-term product stability. The capsules are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, specialty pharmacies, and global pharmaceutical distributors.
₹ 50 / Piece Get Latest Price
| Strength | 1 mg |
| Vial Volume | 1 ml |
| Brand | Vincristyra |
| Concentration | 1 mg/ml |
| Route of Administration | IV |
| Indication | Rhabdomyosarcoma, Wilms Tumor, Lymphoma, Neuroblastoma |
| Form | Lyophilized Powder |
| Packaging Type | Vial |
| Storage | 2–8°C |
| Product Manufacturer | Medyra Pharmaceutical |
Vincristyra 1 Injection
Composition: Vincristine Injection 1mg
International Trade Name: Oncovin®
Vincristyra 1 is a high-quality Vincristine 1mg Injection, a generic equivalent of the internationally recognized chemotherapy drug Oncovin. Manufactured in WHO-GMP certified facilities, Vincristyra 1 is supplied by trusted pharmaceutical exporters from India to meet global oncology treatment requirements.
Vincristine is a vinca alkaloid antineoplastic agent that works by inhibiting microtubule formation in dividing cancer cells, thereby preventing cell division and inducing apoptosis. Vincristyra 1 Injection is widely used in the treatment of leukemias, lymphomas, Wilms’ tumor, neuroblastoma, and other pediatric and adult malignancies.
High-ranking search keywords include: Vincristine injection 1mg, Vincristyra 1 injection, Oncovin generic injection, vincristine price, chemotherapy injection, vincristine exporter India, oncology injectable supplier, and anticancer drug manufacturer India.
Vincristyra 1 Vincristine Injection is supplied in sterile, export-grade vials, ensuring accurate dosing, product stability, and compliance with international pharmaceutical transport and storage standards. It is suitable for hospital oncology departments, cancer treatment centers, and international pharmaceutical distributors.
₹ 5000 / Vial Get Latest Price
| Standard | IP |
| Dosage Form | Injection |
| Brand | Carbotero |
| Treatment | Ovarian Cancer |
| Manufacturer | Hetero Drugs Ltd |
| Strength | 450 mg |
| Storage Temperature | 2-8 degree c |
| Packaging Size | 45 ml |
| Shelf Life | 36 months |
| Composition | Carboplatin |
Carbotero 450 Injection
Composition: Carboplatin Injection 450mg
International Trade Name: Paraplatin®
Carbotero 450 is a high-quality Carboplatin 450mg Injection, a generic equivalent of the internationally recognized platinum-based chemotherapy drug Paraplatin. Manufactured in WHO-GMP certified facilities, Carbotero 450 is supplied by reliable pharmaceutical exporters from India to meet global oncology treatment requirements.
Carboplatin is an alkylating antineoplastic agent that interferes with DNA replication in cancer cells, leading to cell death. Carbotero 450 Injection is widely used in the treatment of ovarian cancer, lung cancer, head and neck cancers, and other solid tumors, either as monotherapy or in combination chemotherapy regimens.
High-ranking search keywords include: Carboplatin 450mg injection, Carbotero 450 injection, Paraplatin generic injection, carboplatin price, platinum chemotherapy drug, carboplatin exporter India, oncology injectable supplier, and anticancer drug manufacturer India.
Carbotero 450 Carboplatin Injection is produced under strict GMP quality standards, ensuring high purity, accurate strength, and reliable therapeutic performance. It is supplied in secure, export-grade packaging, making it suitable for hospital oncology units, cancer treatment centers, and international pharmaceutical distribution networks.
₹ 1203.6 / Strip Get Latest Price
| Strength | 500 mg |
| Brand | Capecitabine |
| Pack Type | Strip |
| Tablets per Pack | 10 Tablets |
| Form | Tablet |
| Usage | Gastric Cancer, Colorectal Cancer, Other Solid Tumor, Breast Cancer |
| Product Manufacturer | Hetero Drugs Ltd |
Capetero 500 Tablets
Composition: Capecitabine Tablets 500mg
International Trade Name: Xeloda®
Capetero 500 is a high-quality Capecitabine 500mg Tablet, a generic equivalent of the internationally recognized oral chemotherapy brand Xeloda. Manufactured in WHO-GMP certified facilities, Capetero 500 is supplied by trusted pharmaceutical exporters from India to support global oncology treatment protocols.
Capecitabine is an oral prodrug of 5-fluorouracil (5-FU) that is selectively activated in tumor tissues, thereby inhibiting DNA synthesis and cancer cell proliferation. Capetero 500 Tablets are widely prescribed in the treatment of breast cancer, colorectal cancer, and gastric cancer, either as monotherapy or in combination chemotherapy regimens.
High-ranking search keywords include: Capecitabine 500mg tablets, Capetero 500 tablets, Xeloda generic tablets, capecitabine price, oral chemotherapy tablets, capecitabine exporter India, oncology tablet supplier, and anticancer drug manufacturer India.
Capetero 500 Capecitabine Tablets are manufactured under strict GMP quality standards, ensuring consistent potency, accurate dosing, and long-term stability. The tablets are packed in secure, export-grade packaging, making them suitable for hospital oncology departments, cancer clinics, and international pharmaceutical distributors.
₹ 3842.75 / Vial Get Latest Price
| Formulation Type | Nanoparticle Albumin-Bound |
| Brand | Paclitero |
| Pharmacopoeia Standard | IP |
| Strength | 100 mg |
| Packaging Size | 16.7 ml |
| Shelf Life | 36 months |
| Storage Temperature | 2-8 degree c |
| Usages | Breast Cancer |
| Packaging Type | Vial |
| Composition | Paclitaxel |
Paclitero 100 Injection
Composition: Paclitaxel Injection 100mg
International Trade Name: Taxol®
Paclitero 100 is a high-quality Paclitaxel 100mg Injection, a generic equivalent of the internationally recognized chemotherapy agent Taxol. Manufactured in WHO-GMP certified facilities, Paclitero 100 is supplied by trusted pharmaceutical exporters from India to meet global oncology treatment requirements.
Paclitaxel is a taxane-class antineoplastic agent that stabilizes microtubules and inhibits cell division, leading to apoptosis of cancer cells. Paclitero 100 Injection is widely used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), Kaposi’s sarcoma, and other solid tumors, either as monotherapy or in combination chemotherapy regimens.
High-ranking search keywords include: Paclitaxel 100mg injection, Paclitero 100 injection, Taxol generic injection, paclitaxel price, taxane chemotherapy drug, paclitaxel exporter India, oncology injectable supplier, and anticancer drug manufacturer India.
Paclitero 100 Paclitaxel Injection is manufactured under strict GMP quality standards, ensuring high purity, accurate strength, and consistent therapeutic performance. It is supplied in secure, export-grade packaging, making it suitable for hospital oncology units, cancer treatment centers, and international pharmaceutical distributors.
Hansaben Kantilal Patel (CEO)
Shivanta Impex
Shop No 04, Shri Ram Kunj, Central Avenue
Bagadganj, Nagpur - 440008, Maharashtra, India